News | Radiation Therapy | August 10, 2016

Accuray CE Marks New Radixact Radiotherapy System

Next-generation image-guided radiation therapy platform and integrated software now available for use by clinicians in the European Union

Accuray, Radixact Treatment Delivery Platform, image-guided radiation therapy, AAPM, CE Mark

August 10, 2016 — Accuray Inc. announced that it has CE marked its Radixact Treatment Delivery System, Accuray Precision Treatment Planning System and iDMS Data Management System. The next-generation hardware and software solutions, together, make up the new Radixact radiation therapy platform, which represents a major step forward in the evolution of Accuray's existing TomoTherapy System in treatment speed and ease of use.

The platform will now be available in certain markets in the European Union (EU), in addition to the U.S. market where it received U.S. Food and Drug Administration (FDA) 510(k) clearance in June 2016.

The Radixact System is a "smart" system that will enable faster, more efficient delivery of extremely precise treatment to a wider range of cancer patients across the European market. It features a more powerful linear accelerator, megavoltage computed tomography (MVCT) imaging and helical treatment delivery, so clinicians can apply highly conformal and homogeneous dose distributions to any target volume, while precisely sparing normal healthy tissue during each treatment fraction.  

The Radixact platform is comprised of three entirely new technologies:

  • Radixact Treatment Delivery System: Taking the capabilities of the TomoTherapy Systems to a new level;
  • Accuray Precision Treatment Planning System: Smart, automated workflows and mid-course decision-making tools that enable clinicians to adapt delivery according to changes in tumor size, shape and location; and
  • iDMS Data Management System: Seamless management of patient data across multiple Radixact Systems and clinics, from a single point of control.

For more information: www.accuray.com

Related Content

Turkish Hospital Begins MR-Guided Radiation Therapy With Viewray MRIdian Linac
News | Image Guided Radiation Therapy (IGRT) | September 21, 2018
ViewRay Inc. announced that Acibadem Maslak Hospital in Istanbul, Turkey has begun treating patients with ViewRay's...
Amar Kishan, M.D.

Amar Kishan, M.D.

News | Prostate Cancer | September 11, 2018
UCLA researchers have discovered that a combination of high doses of...
Videos | Radiation Therapy | September 07, 2018
A discussion with Ehsan Samei, Ph.D., DABR, FAAPM, FSPIE, director of the Duke University Clinical Imaging Physics Gr
Boston Scientific to Acquire Augmenix Inc.
News | Patient Positioning Radiation Therapy | September 07, 2018
Boston Scientific has entered into a definitive agreement to acquire Augmenix Inc., a privately-held company which has...
Non-Canonical Strategy May Improve Cancer Radiotherapy
News | Radiation Therapy | August 29, 2018
August 29, 2018 — Although the success or failure of...
Videos | Treatment Planning | August 28, 2018
A discussion with...
Sponsored Content | Webinar | Radiation Therapy | August 28, 2018
Respiratory tumor motion often complicates the delivery of precision radiation treatment.
Tsuyama Chuo Proton Beam Center Treats First Patients With RayStation
News | Treatment Planning | August 27, 2018
Tsuyama Chuo Hospital in Okayama Prefecture, southwest Japan, has commenced clinical use of RayStation to plan pencil...
Radiation Therapy Affects Event Recall for Children With Brain Tumors
News | Radiation Therapy | August 24, 2018
Children with certain types of brain tumors who undergo radiation treatment are less likely to recall the specifics of...
Videos | Artificial Intelligence | August 23, 2018
Radiological Society of North America (RSNA) President...